Terms: = Endocrine gland cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
194 results:
1. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
[TBL] [Abstract] [Full Text] [Related]
2. Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF; Hinterleitner C; Kiefer LS; Singer S; Mattern S; Schwenck J; Reischl G; Sipos B; Lauer UM; Dittmann H; Zender L; la Fougère C; Hinterleitner M
Clin Nucl Med; 2024 Mar; 49(3):207-214. PubMed ID: 38271237
[TBL] [Abstract] [Full Text] [Related]
3. Methylation of brd4 by PRMT1 regulates brd4 phosphorylation and promotes ovarian cancer invasion.
Liu Y; Liu H; Ye M; Jiang M; Chen X; Song G; Ji H; Wang ZW; Zhu X
Cell Death Dis; 2023 Sep; 14(9):624. PubMed ID: 37737256
[TBL] [Abstract] [Full Text] [Related]
4. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract] [Full Text] [Related]
5. Arterial events in cancer patients treated with apixaban for venous thrombosis.
Larsen TL; Svalastoga M; Brekke J; Enden T; Frøen H; Garresori H; Jacobsen EM; Paulsen PQ; Porojnicu AC; Ree AH; Torfoss D; Velle EO; Wik HS; Ghanima W; Sandset PM; Dahm AEA
Thromb Res; 2023 Aug; 228():128-133. PubMed ID: 37327527
[TBL] [Abstract] [Full Text] [Related]
6. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
Wilson GC; Patel SH; Wang J; Xu K; Turner KM; Becker KA; Carpinteiro A; Szabo I; Ahmad SA; Gulbins E
J Mol Med (Berl); 2023 Jul; 101(7):891-903. PubMed ID: 37246980
[TBL] [Abstract] [Full Text] [Related]
7. Pathologic Tumor Regression is Associated With Improved Survival in Pancreatic cancer.
Nicolais LM; Caron M; Verdini N; Fitzgerald TL
Am Surg; 2023 Sep; 89(9):3778-3783. PubMed ID: 37227766
[TBL] [Abstract] [Full Text] [Related]
8. Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.
Quintela M; James DW; Pociute A; Powell L; Edwards K; Coombes Z; Garcia J; Garton N; Das N; Lutchman-Singh K; Margarit L; Beynon AL; Rioja I; Prinjha RK; Harker NR; Gonzalez D; Conlan RS; Francis LW
Clin Epigenetics; 2023 Apr; 15(1):63. PubMed ID: 37060086
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma.
Bao QR; Frigerio I; Tripepi M; Marletta S; Martignoni G; Giardino A; Regi P; Scopelliti F; Allegrini V; Girelli R; Pucciarelli S; Spolverato G; Butturini G
Pancreatology; 2023 Apr; 23(3):266-274. PubMed ID: 36841686
[TBL] [Abstract] [Full Text] [Related]
10. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
[TBL] [Abstract] [Full Text] [Related]
11. Synergistic effect of PARP inhibitor and brd4 inhibitor in multiple models of ovarian cancer.
Huang Y; Liu C; You L; Li X; Chen G; Fan J
J Cell Mol Med; 2023 Mar; 27(5):634-649. PubMed ID: 36753396
[TBL] [Abstract] [Full Text] [Related]
12. Novel Approaches for the Solid-Phase Synthesis of Dihydroquinazoline-2(1
Wang Q; Pan Y; Luo H; Zhang Y; Gao F; Wang J; Zheng J
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500678
[TBL] [Abstract] [Full Text] [Related]
13. Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1).
Janssen BV; van Roessel S; van Dieren S; de Boer O; Adsay V; Basturk O; Brosens L; Campbell F; Chatterjee D; Chou A; Doglioni C; Esposito I; Feakins R; Fuchs TL; Fukushima N; Gill AJ; Hong SM; Hruban RH; Kaplan J; Krasinkas A; Luchini C; Shi C; Singhi A; Thompson E; Velthuysen MF; Besselink MG; Verheij J; Wang H; Verbeke C; Fariña A;
Br J Surg; 2022 Dec; 110(1):67-75. PubMed ID: 36331867
[TBL] [Abstract] [Full Text] [Related]
14. Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (brd4) expression mediation via sponging microRNA (miR)-140-3p.
Zhu DD; Yu XB; Jiang W; Zhu Y
Bioengineered; 2022 May; 13(5):13607-13621. PubMed ID: 35765893
[TBL] [Abstract] [Full Text] [Related]
15. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract] [Full Text] [Related]
16. Cold Atmospheric Plasma Does Not Affect Stellate Cells Phenotype in Pancreatic cancer Tissue in Ovo.
Privat-Maldonado A; Verloy R; Cardenas Delahoz E; Lin A; Vanlanduit S; Smits E; Bogaerts A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216069
[TBL] [Abstract] [Full Text] [Related]
17. Design, synthesis and mechanism studies of novel dual PARP1/brd4 inhibitors against pancreatic cancer.
Huang SH; Cao R; Lin QW; Wu SQ; Gao LL; Sun Q; Zhu QH; Zou Y; Xu YG; Wang SP
Eur J Med Chem; 2022 Feb; 230():114116. PubMed ID: 35091172
[TBL] [Abstract] [Full Text] [Related]
18. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract] [Full Text] [Related]
19. Propofol Inhibits Thyroid cancer Cell Proliferation, Migration, and Invasion by Suppressing SHH and PI3K/AKT Signaling Pathways via the miR-141-3p/brd4 Axis.
Zhang H; Tan M; Zhang J; Han X; Ma Y
J Healthc Eng; 2021; 2021():2704753. PubMed ID: 34956562
[TBL] [Abstract] [Full Text] [Related]
20. AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.
Liu C; Huang Y; Qin T; You L; Lu F; Hu D; Xiao R; Qin X; Guo E; Yang B; Li X; Fan J; Li X; Fu Y; Liu S; Wang Z; Dou Y; Wang W; Li W; Yang X; Liu J; Peng W; Zhang L; Cui Y; Sun C; Chen G
Cancer Lett; 2022 Mar; 528():31-44. PubMed ID: 34942306
[TBL] [Abstract] [Full Text] [Related]
[Next]
